Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06270147 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Timing of TAP Blocks in Bariatric Surgery

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 25, 2024 (before its estimated January 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Notable Trial status: Not Yet Recruiting to Recruiting Primary completion date: Jun 28, 2024 to Jan 31, 2025 · Start date changed from estimate of Mar 4, 2024 to Nov 21, 2024 · Completion date: Jun 28, 2024 to Jun 28, 2025v2 Show 3 more changesShow less
    • Primary completion date: Jun 28, 2024 to Jan 31, 2025
    • Start date changed from estimate of Mar 4, 2024 to Nov 21, 2024
    • Completion date: Jun 28, 2024 to Jun 28, 2025
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This clinical trial aims to determine the optimal timing for administering a Transversus Abdominis Plane (TAP) block in bariatric surgery, specifically investigating whether initiating TAP blocks at the beginning of surgery is more beneficial than at the end, which is the current practice. The study targets obese patients undergoing bariatric surgery, with a focus on reducing postoperative pain and opioid use. Key outcomes include recovery duration, pain levels, opioid consumption, and respiratory function. Successful results could establish early TAP block initiation as a standard practice, offering faster recovery, decreased opioid reliance, and reduced healthcare costs.
Trial Details
NCT Number NCT06270147
Lead Sponsor McMaster University
Conditions Opioid Use, Pain, Postoperative
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov